Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

CRBU

Caribou Biosciences (CRBU)

Caribou Biosciences Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CRBU
日付受信時刻ニュースソース見出しコード企業名
2024/06/1505 : 03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
2024/06/0319 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
2024/06/0308 : 00GlobeNewswire Inc.Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CRBUCaribou Biosciences Inc
2024/05/3105 : 01GlobeNewswire Inc.Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
2024/05/0805 : 11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
2024/05/0805 : 05GlobeNewswire Inc.Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
2024/05/0205 : 05GlobeNewswire Inc.Caribou Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
2024/04/2423 : 00GlobeNewswire Inc.Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CRBUCaribou Biosciences Inc
2024/04/1522 : 00GlobeNewswire Inc.Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)NASDAQ:CRBUCaribou Biosciences Inc
2024/04/0505 : 00GlobeNewswire Inc.Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in LupusNASDAQ:CRBUCaribou Biosciences Inc
2024/03/1206 : 08Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CRBUCaribou Biosciences Inc
2024/03/1205 : 25Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CRBUCaribou Biosciences Inc
2024/03/1205 : 22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
2024/03/1205 : 05GlobeNewswire Inc.Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
2024/03/0606 : 30GlobeNewswire Inc.Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual MeetingNASDAQ:CRBUCaribou Biosciences Inc
2024/02/2307 : 28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
2024/02/2307 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
2024/02/2307 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
2024/02/2307 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
2024/02/2307 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
2024/02/2307 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
2024/02/2307 : 08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
2024/02/2307 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
2024/02/2307 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
2024/02/2306 : 54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
2024/02/1606 : 05GlobeNewswire Inc.Caribou Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
2024/02/0907 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
2024/01/1106 : 18Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
2024/01/1006 : 10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
2024/01/1006 : 07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CRBU

最近閲覧した銘柄

Delayed Upgrade Clock